Literature DB >> 2427633

Expression of the p53 oncogene in acute myeloblastic leukemia.

L J Smith, E A McCulloch, S Benchimol.   

Abstract

We have investigated whether the p53 oncogene is expressed in the blast cells of patients with acute myeloblastic leukemia. p53 protein was detected in the blast cells of 19 out of 34 patients, but not in normal myelopoietic cells. We find a highly significant correlation between p53 protein synthesis in leukemic blast cells and the secondary plating efficiency of these cells (p = 0.0001). The latter provides an estimate for the self renewal capacity of progenitor cells in the blast population. These data indicate that p53 may be involved in leukemic stem cell renewal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427633      PMCID: PMC2188393          DOI: 10.1084/jem.164.3.751

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  A general method for isolation of high molecular weight DNA from eukaryotes.

Authors:  N Blin; D W Stafford
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

3.  Colony assay for proliferative blast cells circulating in myeloblastic leukaemia.

Authors:  R N Buick; J E Till; E A McCulloch
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

4.  SV40-53K antigen: a possible role for 53K in normal cells.

Authors:  J Milner; S Milner
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

Review 5.  Hemopoietic stem cell differentiation.

Authors:  J E Till; E A McCulloch
Journal:  Biochim Biophys Acta       Date:  1980-11-26

6.  Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia.

Authors:  R N Buick; M D Minden; E A McCulloch
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

7.  Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia.

Authors:  M D Minden; R N Buick; E A McCulloch
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

8.  Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer.

Authors:  R G Wiggans; R J Jacobson; P J Fialkow; P V Woolley; J S Macdonald; P S Schein
Journal:  Blood       Date:  1978-10       Impact factor: 22.113

9.  Acute nonlymphocytic leukemia: heterogeneity of stem cell origin.

Authors:  P J Fialkow; J W Singer; J W Adamson; K Vaidya; L W Dow; J Ochs; J W Moohr
Journal:  Blood       Date:  1981-06       Impact factor: 22.113

10.  Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein.

Authors:  L V Crawford; D C Pim; E G Gurney; P Goodfellow; J Taylor-Papadimitriou
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  11 in total

1.  Characterization of the human p53 gene promoter.

Authors:  S P Tuck; L Crawford
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

2.  Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.

Authors:  H Ahuja; M Bar-Eli; S H Advani; S Benchimol; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells.

Authors:  J J Ryan; R Danish; C A Gottlieb; M F Clarke
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

4.  High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene.

Authors:  A Lavigueur; V Maltby; D Mock; J Rossant; T Pawson; A Bernstein
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

5.  Translational regulation of human p53 gene expression.

Authors:  L Fu; M D Minden; S Benchimol
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

6.  Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.

Authors:  J Cheng; M Haas
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

Review 7.  Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.

Authors:  April D Sorrell; Carin R Espenschied; Julie O Culver; Jeffrey N Weitzel
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

8.  Introduction of new genetic material into human myeloid leukemic blast stem cells by retroviral infection.

Authors:  L J Smith; S Benchimol
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

9.  Correlative study on the expression of p53 and DNA ploidy in acute nonlymphocytic leukemia.

Authors:  F R Lin; E G Yao; L F Zuo; S R Xu; J H Ren; S Y Liu; J P Wei
Journal:  J Tongji Med Univ       Date:  1995

10.  p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression.

Authors:  M Lübbert; C W Miller; L Crawford; H P Koeffler
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.